This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) sank 0.14% to $641.83 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.26% to 4,688.67 and Dow Jones Industrial Average falling 0.58% to 35,931.05. This was the stock's second consecutive day of losses. Regeneron Pharmaceuticals Inc. closed $44.79 below its 52-week high ($686.62), which the company achieved on September 3rd.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 0.37% to $163.28, Novartis AG ADR (NOVN.EB) fell 0.01% to $81.90, and Amgen Inc. (AMGN) rose 0.21% to $205.82. Trading volume (439,713) remained 341,205 below its 50-day average volume of 780,918.
Data source: Dow Jones Market Data, FactSet. Data compiled November 17, 2021.
(END) Dow Jones Newswires
November 17, 2021 17:19 ET (22:19 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.